KBI Biopharma specializes in advanced biopharmaceutical development and manufacturing, offering a range of innovative technologies tailored for both mammalian and microbial expression systems. Their SUREtechnology Platform™, powered by Selexis®, is a key component that enhances mammalian cell line development, enabling the rapid generation of high-performance cell lines for the production of various biologics, including monoclonal antibodies, enzymes, and vaccines. This platform addresses common challenges in protein expression, such as transcription and protein folding, allowing for the creation of stable, high-yield cell lines in as little as nine weeks. KBI's proprietary SURE CHO-M Cell Line™ exemplifies their commitment to efficiency and quality, facilitating the production of therapeutic proteins with high titers and streamlined workflows.

In addition to mammalian systems, KBI Biopharma also excels in microbial expression technologies, particularly through their PUREplatform™, which focuses on E. coli-based production. This platform is designed for clean and efficient therapeutic protein production, ensuring exceptional quality and increased efficiencies. KBI's comprehensive services encompass all stages of biopharmaceutical development, from cell line development and process optimization to analytical development and commercial manufacturing. Their expertise in both mammalian and microbial systems positions KBI as a leader in the contract development and manufacturing organization (CDMO) space, dedicated to advancing new biologics and improving patient outcomes globally.

United States

KBI Biopharma is an award-winning biopharmaceutical contract services organization providing fully-integrated, accelerated drug development and biomanufacturing services to pharmaceutical and biotechnology companies globally.

With each of our 500+ client partners, we have worked closely to personalize and rapidly accelerate their drug development programs. Built upon a foundation of world-class analytical capabilities, we deliver efficient process development and clinical and commercial cGMP manufacturing services for mammalian and microbial programs.

KBI is proud to be a JSR Life Sciences Company.

KBI Biopharma

Company Details